UP FDA Orders Inspection At Pharmacy Outlets Run Under PMBJP Scheme

Lucknow : Uttar Pradesh’s health regulatory agency has ordered an inspection at all pharmacy outlets run under the central government’s affordable medicine scheme, Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana (PMBJP), News18 has learnt.

While the letter written by the state’s drug regulatory agency hinted at quality concerns, the top official explained that the state regulator suspects that the sellers are promoting branded medicines at the stores — defeating the purpose of the scheme to promote the use of “generic medicines” which are about fifty per cent cheaper.

According to the letter written by UP’s Food and Drug Administration cell, all drug inspectors in the state have been ordered to inspect the premises under the scheme.

On June 14, the letter said that in a meeting of the Uttar Pradesh Legislative Council – on the prevention of health problems due to adulteration of food items and circulation of spurious drugs – the decision was taken to inspect all Pradhan Mantri Jan Aushadhi Kendras operating in the state.

Titled “In relation to the inspection of Pradhan Mantri Jan Aushadhi Kendras operating in the state”, the letter directs officials to submit the report within a week.

“…you are directed to inspect all the Pradhan Mantri Jan Aushadhi Kendras operating in your respective areas within a week and make sure to provide the inspection report to the concerned drug licensing authority and inform the action taken to this office as well,” said the letter dated June 15.

While the letter, accessed by News18, gives a hint about testing the medicines for checking the quality of products, the states’ drug controller informed that the investigation has been ordered to identify the store operators who have been selling branded medicines at these generic medicine shops.

“We have been informed that many shops – run under the scheme – are selling other branded medicines also. This defeats the purpose of Jan Aushadhi Kendras,” SK Chaurasia, drug regulator, Uttar Pradesh, told News18. “While currently, the orders do not include sampling and testing of drugs, however, if needed, we will pick samples also.”

  • Related Posts

    ‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

    On Thursday, Congress workers held protests against the “degrading medical conditions of Rajasthan” and attempted to enter the hospital premises. Rajasthan Health Minister Gajendra Singh Khinvsar’s remarks about women diagnosed…

    Price cap on 2 key cancer drugs increased by 50%

    NEW DELHI: Amid concerns over shortages of two critical cancer medicines, National Pharmaceutical Pricing Authority has approved a 50% hike in ceiling prices of Carboplatin and Cisplatin injections, citing escalating…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    ‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

    ‘Did patients come dancing?’ – Rajasthan minister’s remarks about kidney failure case spark row

    Price cap on 2 key cancer drugs increased by 50%

    Price cap on 2 key cancer drugs increased by 50%

    Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

    Hospitals can’t force patients to buy medicines from their pharmacies: Maha FDA

    IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

    IIT Bhubaneswar researchers develop portable device for accurate arsenic detection

    Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

    Bribe of Rs 3 crore: Delhi Police inspector held, senior public servant under CBI scanner

    No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case

    No raids till further orders: Maharashtra tells Bombay HC in Patanjali labelling case